Rosenberger Christian, Rosen Seymour, Heyman Samuel N
Nephrology and Critical Care, Virchow Charitè University Clinic, Berlin, Germany.
Clin Exp Pharmacol Physiol. 2006 Oct;33(10):980-8. doi: 10.1111/j.1440-1681.2006.04472.x.
The pathogenesis of acute kidney injury (AKI), formally termed acute tubular necrosis, is complex and, phenotypically, may range from functional dysregulation without overt morphological features to literal tubular destruction. Hypoxia results from imbalanced oxygen supply and consumption. Increasing evidence supports the view that regional renal hypoxia occurs in AKI irrespective of the underlying condition, even under circumstances basically believed to reflect 'direct' tubulotoxicity. However, at present, it is remains unclear whether hypoxia per se or, rather, re-oxygenation (possibly through reactive oxygen species) causes AKI. Data regarding renal hypoxia in the clinical situation of AKI are lacking and our current concepts regarding renal oxygenation during acute renal failure are presumptive and largely derived from experimental studies. There is robust experimental evidence that AKI is often associated with altered intrarenal microcirculation and oxygenation. Furthermore, renal parenchymal oxygen deprivation seems to participate in the pathogenesis of experimental AKI, induced by exogenous nephrotoxins (such as contrast media, non-steroidal anti-inflammatory drugs or amphotericin), sepsis, pigment and obstructive nephropathies. Sub-lethal cellular hypoxia engenders adaptational responses through hypoxia-inducible factors (HIF). Forthcoming technologies to modulate the HIF system form a novel potential therapeutic approach for AKI.
急性肾损伤(AKI),正式名称为急性肾小管坏死,其发病机制复杂,从表型上看,可能从无明显形态学特征的功能失调到肾小管的实际破坏。缺氧是由氧供应和消耗失衡导致的。越来越多的证据支持这样一种观点,即无论潜在病因如何,AKI都会出现局部肾缺氧,即使在基本被认为反映“直接”肾小管毒性的情况下也是如此。然而,目前尚不清楚是缺氧本身还是复氧(可能通过活性氧)导致了AKI。缺乏关于AKI临床情况下肾缺氧的数据,我们目前关于急性肾衰竭期间肾氧合的概念是推测性的,并且很大程度上来自实验研究。有确凿的实验证据表明,AKI常与肾内微循环和氧合改变有关。此外,肾实质缺氧似乎参与了由外源性肾毒素(如造影剂、非甾体抗炎药或两性霉素)、败血症、色素和梗阻性肾病引起的实验性AKI的发病机制。亚致死性细胞缺氧通过缺氧诱导因子(HIF)引发适应性反应。即将出现的调节HIF系统的技术为AKI形成了一种新的潜在治疗方法。